2329 — Glory Health Industry Income Statement
0.000.00%
Last trade - 00:00- HK$160.00m
- HK$26.94bn
- CNY2.71bn
Annual income statement for Glory Health Industry, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,769 | 9,898 | 3,905 | 2,506 | 2,705 |
| Cost of Revenue | |||||
| Gross Profit | 1,045 | 1,247 | 114 | -50.3 | 556 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,999 | 8,816 | 4,323 | 2,604 | 3,010 |
| Operating Profit | 770 | 1,082 | -419 | -97.8 | -305 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 517 | 877 | -1,090 | -679 | -1,436 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 134 | 345 | -995 | -594 | -1,416 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 98.7 | 228 | -913 | -564 | -1,240 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 98.7 | 228 | -913 | -564 | -1,240 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.023 | 0.003 | -0.204 | -0.14 | -0.268 |
| Dividends per Share |